Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pinedo

Showing results (161-170 of 569) with videos related to

Pageof 57
Sort By:
European Journal of Cancer & Clinical Oncology|December 1, 1985
The absence of influence of acetylsalicylic acid (ASA) on the transient decrease in platelet counts observed after infusion of bleomycin and vinblastineJ Verweij, D M Kester, W P Breed, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1986
The cold pressor test during radionuclide ventriculography: a feasibility study in cancer patientsJ Verwey, A Van Lingen, J J Teule, et al.
Cancer Treatment Reports|June 1, 1986
Clinical and pharmacokinetic studies of prolonged administration of high-dose uridine intended for rescue from 5-FU toxicityC J van Groeningen, A Leyva, I Kraal, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Reaction kinetics of cisplatin and its monoaquated species with the (potential) renal protecting agents (di)mesna and thiosulfate. Estimation of the effect of protecting agents on the plasma and peritoneal AUCs of CDDPO R Leeuwenkamp, W J van der Vijgh, J P Neijt, et al.
Biochemical Pharmacology|April 12, 1996
Regulation of phosphorylation of deoxycytidine and 2',2'-difluorodeoxycytidine (gemcitabine); effects of cytidine 5'-triphosphate and uridine 5'-triphosphate in relation to chemosensitivity for 2',2'-difluorodeoxycytidineV W van Haperen, G Veerman, J B Vermorken, et al.
International Journal of Cancer|April 22, 1992
Comparison of 131I-labelled anti-episialin 139H2 with cisplatin, cyclophosphamide or external-beam radiation for anti-tumor efficacy in human ovarian cancer xenograftsC F Molthoff, H M Pinedo, H M Schlüper, et al.
Journal of the National Cancer Institute|January 18, 1989
Reversal of 5-fluorouracil-induced myelosuppression by prolonged administration of high-dose uridineC J van Groeningen, G J Peters, A Leyva, et al.
Biochemical Pharmacology|November 6, 1991
The chemical reactivity of the modulating agent WR2721 (ethiofos) and its main metabolites with the antitumor agents cisplatin and carboplatinM Treskes, U Holwerda, I Klein, et al.
Archives of Biochemistry and Biophysics|January 1, 1988
Estimation of rRNA synthesis and degradation rates in senescing wheat leavesL Lamattina, M Pinedo, V P Yudi, et al.
Journal of Experimental Therapeutics & Oncology|January 1, 1996
Multidrug resistance-modifying components in human plasma with potential clinical significanceH S Mülder, H M Pinedo, A T Timmer, et al.
Pageof 57

Showing results (161-170 of 569) with videos related to

Sort By:
Pageof 57
European Journal of Cancer & Clinical Oncology|December 1, 1985
The absence of influence of acetylsalicylic acid (ASA) on the transient decrease in platelet counts observed after infusion of bleomycin and vinblastineJ Verweij, D M Kester, W P Breed, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1986
The cold pressor test during radionuclide ventriculography: a feasibility study in cancer patientsJ Verwey, A Van Lingen, J J Teule, et al.
Cancer Treatment Reports|June 1, 1986
Clinical and pharmacokinetic studies of prolonged administration of high-dose uridine intended for rescue from 5-FU toxicityC J van Groeningen, A Leyva, I Kraal, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Reaction kinetics of cisplatin and its monoaquated species with the (potential) renal protecting agents (di)mesna and thiosulfate. Estimation of the effect of protecting agents on the plasma and peritoneal AUCs of CDDPO R Leeuwenkamp, W J van der Vijgh, J P Neijt, et al.
Biochemical Pharmacology|April 12, 1996
Regulation of phosphorylation of deoxycytidine and 2',2'-difluorodeoxycytidine (gemcitabine); effects of cytidine 5'-triphosphate and uridine 5'-triphosphate in relation to chemosensitivity for 2',2'-difluorodeoxycytidineV W van Haperen, G Veerman, J B Vermorken, et al.
International Journal of Cancer|April 22, 1992
Comparison of 131I-labelled anti-episialin 139H2 with cisplatin, cyclophosphamide or external-beam radiation for anti-tumor efficacy in human ovarian cancer xenograftsC F Molthoff, H M Pinedo, H M Schlüper, et al.
Journal of the National Cancer Institute|January 18, 1989
Reversal of 5-fluorouracil-induced myelosuppression by prolonged administration of high-dose uridineC J van Groeningen, G J Peters, A Leyva, et al.
Biochemical Pharmacology|November 6, 1991
The chemical reactivity of the modulating agent WR2721 (ethiofos) and its main metabolites with the antitumor agents cisplatin and carboplatinM Treskes, U Holwerda, I Klein, et al.
Archives of Biochemistry and Biophysics|January 1, 1988
Estimation of rRNA synthesis and degradation rates in senescing wheat leavesL Lamattina, M Pinedo, V P Yudi, et al.
Journal of Experimental Therapeutics & Oncology|January 1, 1996
Multidrug resistance-modifying components in human plasma with potential clinical significanceH S Mülder, H M Pinedo, A T Timmer, et al.
Pageof 57